2021年版《亚太膝关节和髋关节置换术和髋部骨折手术静脉血栓栓塞共识:静脉血栓栓塞症的药物预防》解读

Interpretation of 2021 Asia-Pacific Venous Thromboembolism Consensus in Knee and Hip Arthroplasty and Hip Fracture Surgery:Pharmacological Venous Thromboembolism Prophylaxis

2021年8月,亚太地区骨科专家小组制定了《亚太膝关节和髋关节置换术和髋部骨折手术静脉血栓栓塞共识:静脉血栓栓塞症的药物预防》,主要内容涉及静脉血栓栓塞症的药物预防,详细介绍了目前骨科常用的预防血栓的药物及疗程,骨科大手术预防方案之间的差异,以及针对骨科的血栓和出血风险的评估等。该文对其进行解读,为骨科使用抗凝药物预防血栓提供参考。

In August 2021,Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery were announced by the Asia-Pacific orthopaedic experts.Main contents of the consensus involve in drug prevention of venous thromboembolism(VTE),introduce the commonly used drugs and treatment to prevent blood clots in detail,illustrate the differences in prevention programs of major orthopedic surgery,and provide orthopaedic assessments of the risks of thrombosis and bleeding.In this paper,as the interpretation of the agreement,we aim to provide reference for the orthopaedic use of anticoagulant drugs to prevent blood clots.